Contact
Please use this form to send email to PR contact of this press release:
vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold
TO:
Please use this form to send email to PR contact of this press release:
vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold
TO: